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Link between cardiovascular disease and spinal cord injury:
New evidence and update
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According to the most recent report by the National Spinal Cord Injury Statistical Center, 
hypertensive disorders and the resulting ischemic heart disease constitute the third leading 
cause of mortality in patients with spinal cord injuries (SCI).1 Increased vascular and 
inflammatory markers are indicators of increased cardiovascular risk.2 Abnormal 
cardiovascular control is related to the level and severity of injury to descending autonomic 
(sympathetic) pathways.3 The results of a systematic review covering studies published in 
English from 1990 to 2007 indicated that the quality of evidence regarding SCI status as an 
independent predictor of cardiovascular morbidity and mortality was suboptimal.4 The 
limited number of studies that investigated a link between CVD and SCI had small sample 
size, lacked appropriate control groups or adjustment for key confounders, and varied 
widely in reported outcomes.
In this issue of Neurology®, Cragg et al.5 test the hypothesis that compared to able-bodied 
individuals, patients with SCI are more likely to develop CVD. More than 60,000 
participants in this cross-sectional study were identified from the 2010 Cycle of the National 
Canadian Community Health Survey. The primary outcome measures in this analysis were 
self-reported heart disease and stroke. Participants with SCI were identified using the 
following question: “Do you have a neurological condition caused by a spinal cord injury?” 
All self-reported information was collected using the following statement: “Remember, 
we’re interested in conditions diagnosed by a health professional.” The authors carefully 
reviewed a list of possible confounding variables and factors for exclusion from the analysis: 
those that are associated only with CVD, but not SCI; or associated only with SCI, but not 
CVD; or factors that are the result of SCI that might lead to CVD. Although it is debatable 
whether smoking, obesity, hypertension, physical activity, fruit and vegetable intake, alcohol 
intake, and diabetes meet the definition of confounders, including them in the models did 
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not change the magnitude or significance of the reported associations. After adjusting for 
age and sex in a logistic regression analysis, SCI was associated with increased odds of heart 
disease (adjusted odds ratio [OR] 2.72, 95% confidence interval [CI] 1.94, 3.82) and stroke 
(adjusted OR 3.72, 95% CI 2.22, 6.23).
This study had limitations that should be considered when interpreting the results. Causality 
cannot be established using cross-sectional study designs. Further, no information on 
neurologic level, completeness of injury, etiology of SCI, or heart disease and stroke were 
available. For instance, heart disease and stroke included both atherosclerotic and 
nonatherosclerotic heart disease (such as rheumatic or congenital heart disease). Finally, the 
heart disease and stroke as well as SCI were self-reported. However, as the authors noted, 
although low sensitivity may occur for self-reported data, the specificity of self-reports is 
usually high and the strength of the reported associations is most likely to be underreported 
in the analysis based on low specificity data. Compared to patients without SCI, traditional 
CVD risk factors including a lack of physical activity, overweight and obesity, dyslipidemia, 
abnormalities in glycemic control, and chronic inflammation likely play a similar or even a 
more pronounced role in patients with SCI.6 In addition to these traditional CVD risk 
factors, disturbances in the cardiovascular autonomic function after SCI play a distinctive 
role in the development of cardiovascular complications in individuals with SCI.7 Given that 
timely and careful evaluation of autonomic function in individuals with SCI is essential for 
successful clinical management of these patients, the American Spinal Injury Association 
(ASIA) and the International Spinal Cord Society (IS-CoS) developed the International 
Standards for the assessment of remaining autonomic functions following SCI.8 
Specifically, documenting abnormalities of arterial blood pressure and cardiac rhythm 
(supine hypertension, supine hypotension, orthostatic hypertension, tachycardia, 
bradycardia, and autonomic dysreflexia) is recommended. Additional and more detailed 
information is available at the ASIA Learning Center (http://lms3.learnshare.com/
home.aspx) and the eLearning project of ISCoS (http://www.elearnsci.org/). The degree of 
these autonomic dysfunctions is determined by level of injury and severity of SCI, with the 
most severe cardiovascular consequences observed in complete cervical or high thoracic 
spinal cord injury.9 In most patients with SCI, there is concordance between the impairment 
of sympathetic function and somatic impairment.10
Despite the accumulating evidence on the associations between CVD and SCI, there is a 
lack of evidence-based research to guide clinicians in managing CVD risk factors in patients 
with SCI. Indeed, in the most recent and comprehensive review of evidence-based studies, 
only 2 small clinical trials investigating the effects of pharmacologic treatment of 
dyslipidemia and orthostatic hypertension (n = 52 and n = 4 participants, respectively) were 
identified.6 Moreover, the sample size in 20 other nonrandomized trials and observational 
studies ranged from 6 to 80 participants with the exception of one case-control study that 
was carried out in 1992 among 327 participants with SCI, matched with 327 healthy 
subjects. It is not surprising that few currently available guidelines address the management 
of CVD risk factors in patients with SCI and practically all of them are based on expert 
opinion or results from studies carried out in able-bodied individuals.6 Although the results 
of the study by Cragg et al. take us one step closer to understanding the unique profile of 
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